Substance / Medication

Iron pentacarbonyl

Overview

Active Ingredient
iron carbonyl
RxNorm CUI
262150

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

18 trials linked to this intervention

18
Total Trials
1
Recruiting
7
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Vibrational dynamics of iron pentacarbonyl [Fe(CO)5] in liquid alkanes revisited.
Jouan Armel, Jonusas Mindaugas, Vincent Julien et al. · J Chem Phys · 2025
PMID: 40526565Other
From the Iron Pentacarbonyl Cation to Heteroleptic η-arene Carbonyls and bis-η-arene Cations.
Rall Jan M, Nork Leonie, Engesser Tobias A et al. · Chemistry · 2024
PMID: 38299788Other
Structure and Spectroscopy of Iron Pentacarbonyl, Fe(CO).
Fortes A Dominic, Parker Stewart F · J Am Chem Soc · 2022
PMID: 36112983OtherFull text (PMC)
Synthesis and characterization of a novel composites derived from SBA-15 mesoporous silica and iron pentacarbonyl.
Ruchomski Leszek, Pikula Tomasz, Kamiński Daniel et al. · J Colloid Interface Sci · 2022
PMID: 34750007Other
Synthesis and Characterization of Stable Iron Pentacarbonyl Radical Cation Salts.
Rall Jan M, Schorpp Marcel, Keilwerth Martin et al. · Angew Chem Int Ed Engl · 2022
PMID: 35543697OtherFull text (PMC)
Vibrational dynamics of iron pentacarbonyl in cryogenic matrices.
Thon Raphaël, Chin Wutharath, Chamma Didier et al. · J Chem Phys · 2022
PMID: 35032984Other
Iron pentacarbonyl ligands on silver scorpionates.
Wang Guocang, Noonikara-Poyil Anurag, Fernández Israel et al. · Chem Commun (Camb) · 2022
PMID: 35174823Other
Ultraviolet photodissociation of gas-phase iron pentacarbonyl probed with ultrafast infrared spectroscopy.
Cole-Filipiak Neil C, Troß Jan, Schrader Paul et al. · J Chem Phys · 2021
PMID: 33832268Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Iron pentacarbonyl (substance)
SNOMED CT
1394007
UMLS CUI
C0876769
RxNorm CUI
262150

Clinical Data

This intervention maps to 9 entities in the Healos knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
18
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.